683 Capital Management »

Mbx Biosciences shares owned by 683 Capital Management

Quarter-by-quarter ownership of Mbx Biosciences (MBX) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Mbx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Mbx Biosciences held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mbx Biosciences by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.0M 284k 17.50

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Mbx Biosciences

Frazier Life Sciences Management
Wellington Management Company
OrbiMed Advisors
NEA Management Company
Deep Track Capital
NVP Associates
EcoR1 Capital
Kynam Capital Management
BlackRock
Vanguard Group
Driehaus Capital Management
Franklin Resources
Cormorant Asset Management
Woodline Partners
Citadel Advisors

View all funds holding Mbx Biosciences